MSTX - Mast Therapeutics, Inc Mon 27'th Feb 2017
Stock analysis for Mon 27'th Feb 2017 (Updated daily)
Sell candidate since 2017-02-21
Mast Therapeutics, Inc Stock Analysis
No changes to the price of Mast Therapeutics, Inc in the last trading day. The price has fallen in 9 of the last 10 days and is down by -19.18% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1.94 million shares and in total, 3.01 million shares bought and sold for approx. USD 360 827.
Given the current short-term trend, the stock is expected to rise 36.5% during the next 3 months and, with 90% probability hold a price between USD 0.16 and USD 0.26 at the end of this period.
There are few to none technical positive signals at the moment. Mast Therapeutics, Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at USD 0.12 and USD 0.13. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday February 10, 2017, which indicates further falls until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This doesnâ€™t cause any direct divergence but may be an early warning and a possible "turning point".
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 29 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at USD 0.11 and USD 0.10. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 0.12, USD 0.14 and USD 0.13.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Mast Therapeutics, Inc finds support just below today's level at 0.11. If this is broken, then the next support from accumulated volume will be at 0.10 and 0.09. The stock is about to test the resistance from accumulated volume at USD 0.12 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with periodic low trading volume this stockstock is considered to be "high risk". During the last day, the stock moved USD 0.00 between high and low, or 4.35%. For the last week the stock has had a daily average volatility of 4.42%.
Mast Therapeutics, Inc is oversold on RSI14 (29). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
The stockstock holds several negative signals and despite the positive trend we believe Mast Therapeutics, Inc to perform weak in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.